Patents by Inventor David Dukhan

David Dukhan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5-Aza-7-deazapurine derivatives for treating Flaviviridae
    Publication number: 20060040944
    Abstract: This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-flavivirus or anti-pestivirus, biologically active compound has a 5-aza-7-deazapurine moiety. The 5-aza-7-deazapurine moiety may be substituted or unsubstituted, and may comprise a nucleoside analogue, or a salt or prodrug thereof. The compound of the present invention may be administered alone or in combination with another anti-hepatitis C, anti-flavivirus and/or anti-pestivirus agent.
    Type: Application
    Filed: June 23, 2005
    Publication date: February 23, 2006
    Inventors: Gilles Gosselin, Frank Seela, Paolo La Colla, Richard Storer, David Dukhan, Frederic Leroy
  • Purine nucleoside analogues for treating Flaviviridae including hepatitis C
    Publication number: 20050075309
    Abstract: This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-HCV biologically active pentofuranonucleoside where the pentofuranonucleoside base is an optionally substituted 2-azapurine. The optionally substituted pentofuranonucleoside, or a salt or prodrug thereof, may be administered alone or in combination with one or more optionally substituted pentofuranonucleosides or other anti-viral agents.
    Type: Application
    Filed: July 26, 2004
    Publication date: April 7, 2005
    Inventors: Richard Storer, Gilles Gosselin, David Dukhan, Frederic Leroy